294.42
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $294.42, with a volume of 717.26K.
It is up +1.58% in the last 24 hours and up +6.63% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$290.13
Open:
$291.745
24h Volume:
717.26K
Relative Volume:
0.33
Market Cap:
$158.47B
Revenue:
$34.76B
Net Income/Loss:
$6.62B
P/E Ratio:
24.09
EPS:
12.223
Net Cash Flow:
$10.61B
1W Performance:
+0.20%
1M Performance:
+6.63%
6M Performance:
+3.06%
1Y Performance:
-10.24%
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AMGN
Amgen Inc
|
294.35 | 156.19B | 34.76B | 6.62B | 10.61B | 12.22 |
![]()
LLY
Lilly Eli Co
|
822.17 | 747.19B | 53.26B | 13.80B | -50.20M | 15.08 |
![]()
JNJ
Johnson Johnson
|
190.39 | 459.32B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
231.78 | 407.19B | 58.33B | 3.73B | 18.24B | 2.1013 |
![]()
NVS
Novartis Ag Adr
|
129.72 | 251.72B | 53.40B | 13.68B | 16.89B | 6.8864 |
![]()
MRK
Merck Co Inc
|
85.59 | 214.78B | 63.43B | 16.42B | 14.72B | 6.4861 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-03-25 | Resumed | Raymond James | Mkt Perform |
May-20-25 | Resumed | Guggenheim | Neutral |
Apr-22-25 | Resumed | Cantor Fitzgerald | Neutral |
Dec-10-24 | Resumed | BofA Securities | Underperform |
Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
Nov-14-24 | Initiated | Citigroup | Neutral |
Oct-17-24 | Initiated | Bernstein | Outperform |
Oct-14-24 | Downgrade | Truist | Buy → Hold |
Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
Mar-28-24 | Resumed | Raymond James | Mkt Perform |
Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Nov-09-23 | Initiated | Deutsche Bank | Hold |
Nov-02-23 | Upgrade | Truist | Hold → Buy |
Oct-20-23 | Resumed | JP Morgan | Neutral |
Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
Oct-11-23 | Resumed | BofA Securities | Neutral |
Sep-06-23 | Initiated | HSBC Securities | Buy |
Apr-24-23 | Reiterated | Oppenheimer | Outperform |
Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Feb-13-23 | Reiterated | Truist | Buy |
Nov-18-22 | Initiated | Credit Suisse | Underperform |
Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
May-23-22 | Initiated | SVB Leerink | Mkt Perform |
Feb-09-22 | Reiterated | Barclays | Equal Weight |
Feb-09-22 | Reiterated | Jefferies | Buy |
Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
Feb-09-22 | Reiterated | Oppenheimer | Outperform |
Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
Dec-06-21 | Initiated | Goldman | Buy |
Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Dec-29-20 | Initiated | Daiwa Securities | Buy |
Oct-28-20 | Initiated | UBS | Neutral |
Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Oct-12-20 | Upgrade | Truist | Hold → Buy |
Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
Oct-09-20 | Downgrade | Truist | Buy → Hold |
Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
Apr-15-20 | Resumed | Guggenheim | Neutral |
Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
Feb-27-20 | Initiated | Barclays | Equal Weight |
Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
Dec-24-19 | Initiated | Raymond James | Mkt Perform |
Dec-17-19 | Resumed | Morgan Stanley | Overweight |
Nov-12-19 | Initiated | SunTrust | Buy |
Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
Oct-17-19 | Resumed | BofA/Merrill | Neutral |
Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Aanika’s Journey: Life After a Severe Asthma Diagnosis - Amgen
Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention - Yahoo Finance
Amgen Inc. $AMGN Shares Bought by Sequoia Financial Advisors LLC - MarketBeat
Concurrent Investment Advisors LLC Boosts Position in Amgen Inc. $AMGN - MarketBeat
Reflecting On Therapeutics Stocks’ Q2 Earnings: Amgen (NASDAQ:AMGN) - TradingView
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(AMGN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
The Best Dividend ETF to Invest $1,000 in Right Now - The Motley Fool
Will Amgen Inc. (AMG0) stock deliver stable dividendsJuly 2025 Review & Technical Pattern Recognition Alerts - newser.com
Keener Financial Planning LLC Raises Stake in Amgen Inc. $AMGN - MarketBeat
With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing - Yahoo Finance
Natural Investments LLC Has $1.05 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Cwm LLC - MarketBeat
Vanguard Personalized Indexing Management LLC Acquires 8,411 Shares of Amgen Inc. $AMGN - MarketBeat
Sather Financial Group Inc Grows Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Fifth Third Wealth Advisors LLC - MarketBeat
Richardson Financial Services Inc. Has $66,000 Position in Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation as Shares Show Renewed Momentum in the Biotech Landscape - simplywall.st
Will Amgen Inc. stock recover after recent drop2025 Support & Resistance & Consistent Profit Alerts - newser.com
Thompson Investment Management Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat
Cyndeo Wealth Partners LLC Has $6.97 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Commerzbank Aktiengesellschaft FI Sells 3,381 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Lowered by Drucker Wealth 3.0 LLC - MarketBeat
Lmcg Investments LLC Sells 2,659 Shares of Amgen Inc. $AMGN - MarketBeat
Horizon Bancorp Inc. IN Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
First Fiduciary Investment Counsel Inc. Buys 1,069 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Is Amgen Inc. (AMGN) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom? - MSN
Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com
AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing - Bioprocess Online
Market reaction to Amgen Inc.’s recent newsMarket Risk Summary & Technical Confirmation Alerts - newser.com
Quantitative breakdown of Amgen Inc. recent moveMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Is Amgen Inc. (AMG0) stock cheap by valuation metricsTrade Volume Summary & Verified Chart Pattern Trade Signals - newser.com
Will Amgen Inc. (AMG0) stock outperform energy sector in 20252025 Winners & Losers & AI Driven Stock Reports - newser.com
Will Amgen Inc. (AMG0) stock benefit from mergersJuly 2025 Momentum & Risk Controlled Swing Trade Alerts - newser.com
Mainstay Capital Management LLC ADV Increases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Boosted by Copperwynd Financial LLC - MarketBeat
What moving averages say about Amgen Inc.July 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - newser.com
US Bancorp DE Has $198.15 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Insight Inv LLC Has $2.10 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Columbus Macro LLC - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Callan Family Office LLC - MarketBeat
Trifecta Capital Advisors LLC Boosts Position in Amgen Inc. $AMGN - MarketBeat
Here's What To Expect From Amgen’s Next Earnings Report - Barchart.com
Will Amgen Inc. stock deliver better than expected guidance2025 Earnings Impact & Short-Term Trading Opportunity Alerts - newser.com
How to forecast Amgen Inc. trends using time seriesEarnings Miss & Advanced Technical Signal Analysis - newser.com
Meet Olusope Otuyelu, a 2025 40 Under 40 honoree - The Business Journals
Maryland State Retirement & Pension System Has $7.30 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Massachusetts Wealth Management Takes $1.82 Million Position in Amgen Inc. $AMGN - MarketBeat
First Merchants Corp Has $2.91 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Holdings Lowered by Sitrin Capital Management LLC - MarketBeat
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):